Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Sunday morning musings on managing long-term conditions

“Community pharmacists are extremely famous, but we don’t know what you do.” These are the words of a delegate relaying the uninformed position of his voluntary sector colleagues. Wherever I am lately, this is the predominant question: do people really understand the role of pharmacy?

Discussion arising from the Sunday morning session on the management of long-term conditions, chaired by Peter Knapp, senior lecturer from the Department of Health Sciences at the University of York, was no exception.

Wasim Baqir presented research into patient satisfaction with pharmaceutical care in inflammatory bowel disease, alongside findings about patient loyalty to community pharmacies. It was perhaps unsurprising that almost 50 per cent of patients chose their community pharmacy because of its convenient location. However, delegates joined Mr Baqir’s disappointment that only 3 per cent of patients considered a pharmacist the reason for their loyalty to a particular pharmacy.

This figure arose again later in the day as pharmacist roles were discussed in greater depth during the supervision debate chaired by John Gentle, RPS treasurer. Questions were raised about how pharmacists can promote their clinical expertise and services to patients. The research shared by Mr Baqir finds that patients place a higher value on friendly customer service from pharmacy staff, the availability of specific medicines and services than the clinical expertise available from pharmacists.

Other presentations also explored the changing and challenging pharmacist roles and pharmacy services. Ruey Leng Loo reported that community pharmacists are largely in support of providing NHS health checks. However, in the view of pharmacists, barriers to this include staffing, time restraints, reimbursement and training requirements.

Helen Payton presented results from her MPharm fourth-year research project about the clinical impact of pharmacist-led diabetes outpatient clinics. In light of the recently launched Royal College of General Practitioners report “Care planning – improving the lives of people with long-term conditions”, it was positive to hear results demonstrating that pharmacist-led clinics can provide significant benefits to patients by reducing clinical outcome measures (blood pressure, cholesterol and HbA1c) associated with long-term risk.

Other presentations included research from the School of Pharmacy at Queen’s University Belfast, which explored factors influencing GP prescribing in dementia, and the adherence of children taking antiepileptic medication. So, all in all, Session 3 provided interesting insight for a sleepy Sunday morning!

by Connie Pringle


Citation: The Pharmaceutical Journal URI: 11084034

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.